| Quarterly Financials | Mar 2015 | Jun 2015 | Sept 2015 | Dec 2015 | Mar 2016 | Jun 2016 | Sept 2016 | Dec 2016 | Mar 2017 | Jun 2017 | Sept 2017 | Dec 2017 | Mar 2018 | Jun 2018 | Sept 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sept 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sept 2020 | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
Revenue  | 1,052 | 1,160 | 1,206 | 1,116 | 1,028 | 1,108 | 1,083 | 1,018 | 920 | 928 | 1,077 | 1,042 | 1,010 | 1,015 | 1,132 | 1,048 | 880 | 760 | 705 | 807 | 720 | 2,077 | 730 | 865 | 640 | 861 | 866 | 856 | 669 | 652 | 736 | 701 | 710 | 658 | 777 | 709 | 754 | 769 | 818 | 729 | 758 | 758 | 803 |
| Expenses | 943 | 973 | 1,031 | 1,001 | 945 | 1,016 | 964 | 995 | 1,028 | 1,309 | 1,001 | 959 | 1,024 | 1,003 | 1,058 | 1,064 | 827 | 726 | 670 | 656 | 674 | 1,298 | 697 | 706 | 698 | 739 | 765 | 742 | 871 | 611 | 831 | 657 | 771 | 642 | 681 | 664 | 803 | 648 | 699 | 593 | 679 | 763 | 604 |
| EBITDA | 109 | 187 | 175 | 116 | 83 | 92 | 119 | 23 | -108 | -381 | 76 | 84 | -15 | 12 | 74 | -16 | 53 | 34 | 35 | 151 | 47 | 779 | 33 | 159 | -58 | 122 | 101 | 114 | -202 | 41 | -95 | 44 | -61 | 16 | 96 | 45 | -49 | 121 | 119 | 136 | 79 | -5 | 199 |
| Operating Profit % | 13 % | 15 % | 16 % | 7 % | 6 % | 7 % | 9 % | 0 % | -19 % | -47 % | 2 % | 5 % | -1 % | 0 % | 6 % | -2 % | 4 % | -0 % | 2 % | 12 % | 2 % | -117 % | 2 % | 8 % | -10 % | 14 % | 11 % | 13 % | -33 % | -3 % | -22 % | 6 % | -14 % | 0 % | 10 % | 5 % | -15 % | 12 % | 14 % | 18 % | 9 % | -3 % | 23 % |
| Depreciation | 34 | 35 | 35 | 36 | 37 | 36 | 37 | 38 | 37 | 37 | 36 | 38 | 38 | 39 | 40 | 41 | 45 | 55 | 53 | 56 | 61 | 56 | 57 | 68 | 65 | 64 | 61 | 62 | 59 | 64 | 65 | 66 | 56 | 55 | 55 | 55 | 58 | 54 | 55 | 55 | 53 | 56 | 53 |
| Interest | 14 | 24 | 30 | 32 | 43 | 49 | 56 | 61 | 59 | 61 | 68 | 62 | 65 | 73 | 65 | 64 | 64 | 71 | 65 | 79 | 61 | 74 | 61 | 60 | 55 | 64 | 69 | 80 | 86 | 73 | 70 | 83 | 76 | 79 | 76 | 77 | 73 | 73 | 73 | 60 | 48 | 48 | 55 |
| Profit Before Tax | 60 | 128 | 110 | 48 | 4 | 7 | 26 | -76 | -204 | -480 | -28 | -16 | -118 | -100 | -32 | -121 | -55 | -92 | -82 | 16 | -75 | 649 | -85 | 31 | -178 | -6 | -29 | -28 | -347 | -96 | -230 | -105 | -193 | -118 | -35 | -87 | -180 | -6 | -9 | 21 | -22 | -109 | 91 |
| Tax | 27 | 30 | 12 | -22 | 17 | -9 | 1 | -16 | 3 | -17 | -19 | 27 | 35 | -5 | -1 | -44 | -41 | -55 | 12 | -3 | -144 | -111 | -88 | -1 | -71 | 1 | -66 | -30 | -36 | -21 | -23 | -3 | 44 | 18 | 38 | -1 | -3 | 10 | 7 | 1 | 23 | -1 | 9 |
| Net Profit | 33 | 98 | 98 | 69 | -13 | 17 | 25 | -60 | -207 | -463 | -9 | -43 | -153 | -95 | -31 | -77 | -14 | -37 | -94 | 19 | 69 | 760 | 3 | 32 | -107 | -7 | 37 | 2 | -311 | -75 | -207 | -102 | -237 | -136 | -73 | -86 | -177 | -16 | -16 | 20 | -45 | -108 | 82 |
| EPS in ₹ | 3.10 | 8.36 | 8.37 | 6.52 | -0.49 | 1.44 | 2.25 | -4.88 | -15.81 | -37.06 | -0.80 | -3.69 | -13.97 | -7.79 | -2.06 | -6.42 | -2.62 | -4.06 | -7.42 | 0.87 | 4.36 | 68.64 | 0.32 | 1.38 | -8.38 | -1.15 | 2.79 | -0.61 | -21.20 | -4.64 | -13.15 | -6.62 | -14.37 | -9.28 | -5.37 | -5.75 | -11.64 | -0.95 | -1.47 | 0.91 | -1.57 | -5.53 | 4.81 |
Wockhardt
Wockhardt
1,437.00
-7.90
(-0.55%)
Market Cap
₹23,350.12 Cr
PE Ratio
-460.45
Volume
4,34,423.00
Day High - Low
₹1,461.00 - ₹1,417.00
52W High-Low
₹1,868.80 - ₹1,110.05
Key Fundamentals
Market Cap
23,350.12 Cr
EPS
-3.02
PB Ratio
5.14
Book Value
281.07
EBITDA
455.00
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-1.22
Debt to Equity
0.57
Actual
Company News
View All News
Wockhardt establishes three new step-down subsidiaries in Switzerland and the USA to expand its international operations and strengthen global presence in pharmaceutical markets.
Wockhardt Limited shareholders approve appointment of Om Prakash Bhatt as Non-Executive Independent Director for 5-year term through postal ballot with 99.99% votes in favor.
The USFDA has formally accepted Wockhardt's New Drug Application for its novel antibiotic Zaynich, marking the first time an Indian pharmaceutical company has achieved NDA acceptance for a New Chemical Entity. Zaynich, granted Fast Track designation, targets highly resistant Gram-negative pathogens and represents a transformative moment for both Wockhardt and the entire Indian pharmaceutical industry.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,737.00 | #1 4,16,764.48 | 40.16 | #1 54,729.00 | 9.71 | #1 10,980 | 2.89 | 41.99 | |
6,496.50 | 1,72,461.66 | 69.16 | 9,712.00 | 18.67 | 2,191 | 35.10 | 54.95 | |
3,834.30 | 1,29,770.14 | 60.40 | 11,539.40 | 6.99 | 1,911 | 30.46 | 64.03 | |
1,496.30 | 1,20,864.24 | 22.30 | 28,409.50 | 7.12 | 5,291 | 3.71 | 43.36 | |
1,265.80 | 1,05,645.41 | 18.66 | 33,741.20 | 16.73 | 5,725 | -0.38 | 50.22 | |
2,107.00 | 96,238.18 | 22.21 | 22,909.50 | 13.74 | 3,306 | #1 72.75 | 58.72 | |
917.80 | 92,352.16 | #1 18.57 | 23,511.00 | 18.55 | 4,615 | 34.60 | 41.66 | |
2,193.30 | 90,530.32 | 51.90 | 12,744.20 | #1 20.90 | 2,007 | -21.05 | 47.28 | |
1,211.40 | 70,358.31 | 20.66 | 32,345.60 | 9.43 | 3,484 | 3.81 | 55.09 | |
5,566.00 | 66,549.88 | 27.75 | 13,458.30 | 3.70 | 2,216 | 10.98 | 44.89 |
Automatic Screeners on ScanX
Growth Rate
Revenue Growth
6.70 %
Net Income Growth
-87.92 %
Cash Flow Change
-110.05 %
ROE
-90.54 %
ROCE
-264.98 %
EBITDA Margin (Avg.)
249.88 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Total Assets | 6,939 | 8,121 | 9,022 | 8,162 | 7,844 | 8,179 | 7,774 | 8,243 | 7,683 | 7,649 | 8,135 |
| Fixed Assets | 2,123 | 2,809 | 2,773 | 2,888 | 3,058 | 3,502 | 3,343 | 3,462 | 3,042 | 2,881 | 2,736 |
| Current Assets | 3,522 | 3,952 | 4,535 | 3,380 | 2,815 | 2,430 | 2,425 | 2,589 | 2,208 | 2,073 | 2,465 |
| Capital Work in Progress | 1,007 | 1,036 | 1,244 | 1,433 | 1,446 | 1,585 | 1,379 | 1,342 | 1,539 | 1,722 | 2,033 |
| Investments | 339 | 0 | 563 | 214 | 0 | 0 | 0 | 0 | 0 | 0 | 422 |
| Other Assets | 3,470 | 4,276 | 4,443 | 3,628 | 3,341 | 3,092 | 3,052 | 3,439 | 3,102 | 3,046 | 2,944 |
| Total Liabilities | 6,939 | 8,121 | 9,022 | 8,162 | 7,844 | 8,179 | 7,774 | 8,243 | 7,683 | 7,649 | 8,135 |
| Current Liabilities | 1,773 | 1,842 | 1,979 | 2,692 | 2,864 | 3,497 | 3,121 | 3,207 | 3,435 | 2,791 | 2,042 |
| Non Current Liabilities | 1,307 | 2,039 | 3,324 | 2,272 | 1,976 | 1,624 | 894 | 834 | 586 | 1,196 | 1,436 |
| Total Equity | 3,859 | 4,241 | 3,719 | 3,198 | 3,005 | 3,058 | 3,759 | 4,202 | 3,662 | 3,662 | 4,657 |
| Reserve & Surplus | 3,362 | 3,720 | 3,281 | 2,797 | 2,620 | 2,616 | 3,321 | 3,777 | 3,282 | 3,282 | 4,272 |
| Share Capital | 354 | 55 | 55 | 55 | 55 | 55 | 55 | 72 | 72 | 77 | 81 |
Cash Flow
| Cash Flow | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 57 | 46 | 301 | -66 | -500 | -178 | 13 | 138 | -280 | 415 | -393 |
| Investing Activities | -222 | -106 | -684 | 635 | 93 | -147 | 1,471 | -204 | -118 | -138 | -780 |
| Operating Activities | 355 | -42 | -270 | 68 | 183 | 649 | -287 | 413 | 153 | 219 | -22 |
| Financing Activities | -76 | 193 | 1,255 | -770 | -777 | -680 | -1,171 | -71 | -315 | 334 | 409 |
Share Holding
| % Holding | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Nov 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Promoter | 72.12 % | 69.68 % | 68.04 % | 67.13 % | 67.13 % | 65.75 % | 63.83 % | 60.36 % | 59.31 % | 58.40 % | 55.14 % | 54.93 % | 51.60 % | 51.99 % | 51.99 % | 49.09 % | 49.09 % | 49.09 % | 49.09 % | 49.08 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 3.02 % | 0.00 % | 5.49 % | 5.93 % | 6.70 % | 6.62 % | 6.54 % | 6.81 % | 7.29 % | 7.10 % |
| DIIs | 0.02 % | 0.02 % | 0.02 % | 0.03 % | 0.03 % | 0.03 % | 0.03 % | 0.23 % | 0.22 % | 0.19 % | 0.22 % | 0.10 % | 4.83 % | 4.45 % | 5.09 % | 9.88 % | 9.82 % | 10.59 % | 11.01 % | 11.01 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.01 % | 0.01 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % | 0.02 % |
| Public / Retail | 21.41 % | 23.02 % | 25.24 % | 25.99 % | 24.56 % | 25.97 % | 27.42 % | 30.26 % | 31.45 % | 32.19 % | 32.89 % | 32.94 % | 29.94 % | 30.18 % | 29.02 % | 27.45 % | 27.49 % | 26.69 % | 26.05 % | 26.10 % |
| Others | 6.46 % | 7.27 % | 6.69 % | 6.85 % | 8.28 % | 8.26 % | 8.72 % | 9.15 % | 9.02 % | 9.21 % | 8.72 % | 12.03 % | 8.13 % | 7.43 % | 7.19 % | 6.95 % | 7.04 % | 6.80 % | 6.55 % | 6.69 % |
| No of Share Holders | 0 | 0 | 1,25,128 | 1,44,845 | 1,61,625 | 1,65,270 | 1,66,122 | 1,80,170 | 1,80,630 | 1,78,915 | 1,72,989 | 1,61,813 | 1,46,376 | 1,40,391 | 1,38,142 | 1,43,876 | 1,42,710 | 1,41,799 | 1,46,918 | 1,37,946 |
Dividend History
| Annual Cash Flows | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 10 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 1.49 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
| 09 Mar 2022 |  Rights | 3:10 | 08 Mar 2022 | 311.72 | 308.20 |
| 28 Jun 2024 |  Annual General Meeting | NA | 28 Jun 2024 | 514.90 | 653.75 |
| 13 Nov 2024 |  Quarterly Result Announcement | NA | 13 Nov 2024 | 1,206.50 | 1,180.80 |
| 07 Feb 2025 | Quarterly Result Announcement | NA | 07 Feb 2025 | 1,558.55 | 1,651.10 |
| 29 May 2025 | Quarterly Result Announcement | NA | 29 May 2025 | 1,320.20 | 1,337.10 |
| 08 Aug 2025 | Quarterly Result Announcement | NA | 08 Aug 2025 | 1,667.50 | 1,519.15 |
| 08 Aug 2025 | Annual General Meeting | NA | 08 Aug 2025 | 1,828.00 | 1,519.15 |
| 03 Nov 2025 | Quarterly Result Announcement | NA | 03 Nov 2025 | 1,295.90 | 1,281.50 |
Announcements
Intimation For Incorporation Of Step-Down Subsidiaries Of The Company.
8 days ago
8 days ago Shareholder Meeting / Postal Ballot-Scrutinizer"s Report8 days ago
8 days agoShareholder Meeting / Postal Ballot-Outcome of Postal_Ballot8 days ago
8 days agoReply To Email Related To Volume MovementDec 02, 2025
Dec 02, 2025Clarification sought from Wockhardt LtdDec 02, 2025
Dec 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseDec 01, 2025
Dec 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 28, 2025
Nov 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 15, 2025
Nov 15, 2025Shareholder Meeting / Postal Ballot-Notice of Postal BallotNov 14, 2025
Nov 14, 2025Reply To Your Email Dated 4Th November 2025 Relating To Volume MovementNov 04, 2025
Nov 04, 2025Clarification sought from Wockhardt LtdNov 04, 2025
Nov 04, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseNov 03, 2025
Nov 03, 2025Announcement under Regulation 30 (LODR)-Change in ManagementNov 03, 2025
Nov 03, 2025Un-Audited Financial Results For The Quarter And Half Year Ended 30Th September 2025Nov 03, 2025
Nov 03, 2025Board Meeting Outcome for Outcome Of The Board MeetingNov 03, 2025
Nov 03, 2025Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ( The Company).Oct 29, 2025
Oct 29, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 13, 2025
Oct 13, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseOct 01, 2025
Oct 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 29, 2025
Sep 29, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseSep 25, 2025
Sep 25, 2025Closure of Trading WindowSep 25, 2025
Sep 25, 2025Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 - ESG RatingsSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Credit RatingAug 26, 2025
Aug 26, 2025Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSAug 21, 2025
Aug 21, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportAug 08, 2025
Aug 08, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 08, 2025
Aug 08, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 08, 2025
Aug 08, 2025Outcome Of The Board MeetingAug 08, 2025
Aug 08, 2025Board Meeting Outcome for Outcome Of The Board MeetingAug 08, 2025
Aug 08, 2025Board Meeting Intimation for Intimation Of The Meeting Of Board Of Directors Of Wockhardt Limited ("The Company").Aug 01, 2025
Aug 01, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 31, 2025
Jul 31, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 28, 2025
Jul 28, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Jul 18, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 17, 2025
Jul 17, 2025Business Responsibility and Sustainability Reporting (BRSR)Jul 16, 2025
Jul 16, 2025Intimation Of Record Date For The Purpose Of 25Th Annual General Meeting (AGM) Of The Company.Jul 16, 2025
Jul 16, 2025Notice Of 26Th Annual General Meeting(AGM) Of The Company For The Financial Year 2024-25Jul 16, 2025
Jul 16, 2025Reg. 34 (1) Annual Report.Jul 16, 2025
Jul 16, 2025Reg. 34 (1) Annual Report.Jul 16, 2025
Jul 16, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 11, 2025
Jul 11, 2025Closure of Trading WindowJun 26, 2025
Jun 26, 2025Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJun 11, 2025
Jun 11, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJun 05, 2025
Jun 05, 2025Announcement under Regulation 30 (LODR)-Investor PresentationJun 05, 2025
Jun 05, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 02, 2025
Jun 02, 2025Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 29, 2025
May 29, 2025Announcement under Regulation 30 (LODR)-Change in ManagementMay 29, 2025
May 29, 2025Board Meeting Outcome for Outcome Of The Board MeetingMay 29, 2025
May 29, 2025Mutual Fund Holdings
Mirae Asset Healthcare Fund Direct - Growth 
Bank of India Small Cap Fund Direct-Growth 
HDFC Multi Cap Fund Direct - Growth 
ICICI Prudential Equity & Debt Fund Direct-Growth 
Bandhan Small Cap Fund Direct-Growth 
ITI Focused Fund Direct - Growth 
Nippon India Nifty Smallcap 250 Index Fund Direct - Growth 
JioBlackRock Nifty Smallcap 250 Index Fund Direct - Growth 
Kotak Nifty Smallcap 50 Index Fund Direct - Growth 
Axis Nifty Smallcap 50 Index Fund Direct-Growth 
Motilal Oswal Nifty Smallcap 250 Index Fund Direct - Growth 
SBI Nifty Smallcap 250 Index Fund Direct - Growth 
Edelweiss Nifty Smallcap 250 Index Fund Direct - Growth 
Aditya Birla Sun Life Nifty Smallcap 50 Index Fund Direct-Growth 
Tata Nifty MidSmall Healthcare Index Fund Direct - Growth Technical Indicators
RSI(14)
Neutral 61.71
ATR(14)
Less Volatile 56.43
STOCH(9,6)
Neutral 67.93
STOCH RSI(14)
Overbought 86.86
MACD(12,26)
Bullish 12.09
ADX(14)
Weak Trend 19.60
UO(9)
Bearish 47.38
ROC(12)
Uptrend And Accelerating 6.24
WillR(14)
Neutral -20.31
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
